131950|t|[Exogenous psychosis in a patient with carcinoid syndrome following treatment with p-chlorophenylalanine (PCPA)].
131950|a|A case is reported of a patient with carcinoid syndrome who developed a exogenous psychosis while under treatment with the serotonin-inhibitor p-chlorophenylalanine (PCPA). Partial symptoms similar to delirium and schizophrenia were exhibited. The attached literature survey focuses on the psychological side effects of PCPA treatment. A discussion follows concerning noteworthy phenomenological similarities between the case reported and certain forms of amphetamine psychosis. Common biochemical mechanisms are hypothetically stated.
131950	11	20	psychosis	Disease	MESH:D011618
131950	26	33	patient	Species	9606
131950	39	57	carcinoid syndrome	Disease	MESH:D002276
131950	83	104	p-chlorophenylalanine	Chemical	MESH:D010134
131950	106	110	PCPA	Chemical	MESH:D010134
131950	138	145	patient	Species	9606
131950	151	169	carcinoid syndrome	Disease	MESH:D002276
131950	196	205	psychosis	Disease	MESH:D011618
131950	237	246	serotonin	Chemical	MESH:D012701
131950	257	278	p-chlorophenylalanine	Chemical	MESH:D010134
131950	280	284	PCPA	Chemical	MESH:D010134
131950	315	323	delirium	Disease	MESH:D003693
131950	328	341	schizophrenia	Disease	MESH:D012559
131950	434	438	PCPA	Chemical	MESH:D010134
131950	570	591	amphetamine psychosis	Disease	MESH:D019969
131950	Positive_Correlation	MESH:D010134	MESH:D003693
131950	Negative_Correlation	MESH:D010134	MESH:D002276
131950	Positive_Correlation	MESH:D010134	MESH:D012559
131950	Positive_Correlation	MESH:D010134	MESH:D011618
131950	Negative_Correlation	MESH:D010134	MESH:D012701

